Description: Recombinant, Influenza Hemagglutinin Full-Length Glycoprotein from virus strain A/Vietnam/1203/2004 (H5N1). Recombinant HA (rHA) is supplied as an affinity purified protein. rHA is produced in Sf9 insect cells using baculovirus for expression and is purified by FPLC.
Size: 50 µg of protein is supplied at a concentration of 0.362 mg/mL (by BCA) in Tris buffered saline and 0.01% non-ionic surfactant. The theoretical molecular weight of the protein is ~64 kDa, without glycosylation. Because of the highly glycosylated nature of this protein, migration in an SDS-PAGE gel is slowed resulting in broad, diffuse bands representing differing glycosylation forms.
Relevance: Recombinant hemagglutinin glycoprotein provides a control protein for immunoassays and a tool to enhance Orthomyxovirus research.
Storage: 2-3 weeks at -20°C, -80°C long term
Intended for research use only, not for human, therapeutic, or diagnostic applications.